193 related articles for article (PubMed ID: 23090955)
1. Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense.
Thorslund SE; Ermert D; Fahlgren A; Erttmann SF; Nilsson K; Hosseinzadeh A; Urban CF; Fällman M
Infect Immun; 2013 Jan; 81(1):11-22. PubMed ID: 23090955
[TBL] [Abstract][Full Text] [Related]
2. Yersinia pseudotuberculosis efficiently escapes polymorphonuclear neutrophils during early infection.
Westermark L; Fahlgren A; Fällman M
Infect Immun; 2014 Mar; 82(3):1181-91. PubMed ID: 24379291
[TBL] [Abstract][Full Text] [Related]
3. Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice.
Holmström A; Rosqvist R; Wolf-Watz H; Forsberg A
Infect Immun; 1995 Jun; 63(6):2269-76. PubMed ID: 7768608
[TBL] [Abstract][Full Text] [Related]
4. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches.
Logsdon LK; Mecsas J
Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522
[TBL] [Abstract][Full Text] [Related]
5. Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection.
Shaban L; Nguyen GT; Mecsas-Faxon BD; Swanson KD; Tan S; Mecsas J
PLoS Pathog; 2020 May; 16(5):e1008576. PubMed ID: 32392230
[TBL] [Abstract][Full Text] [Related]
6. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
Fisher ML; Castillo C; Mecsas J
Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
[TBL] [Abstract][Full Text] [Related]
7. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.
Miller HK; Kwuan L; Schwiesow L; Bernick DL; Mettert E; Ramirez HA; Ragle JM; Chan PP; Kiley PJ; Lowe TM; Auerbuch V
PLoS Pathog; 2014 Jun; 10(6):e1004194. PubMed ID: 24945271
[TBL] [Abstract][Full Text] [Related]
8. Impact of CCR7 on T-Cell Response and Susceptibility to Yersinia pseudotuberculosis Infection.
Pezoldt J; Pisano F; Heine W; Pasztoi M; Rosenheinrich M; Nuss AM; Pils MC; Prinz I; Förster R; Huehn J; Dersch P
J Infect Dis; 2017 Sep; 216(6):752-760. PubMed ID: 28329174
[TBL] [Abstract][Full Text] [Related]
9. Attenuation and preserved immunogenic potential of Yersinia pseudotuberculosis mutant strains evidenced in oral pig model.
Najdenski H; Golkocheva-Markova E; Kussovski V; Vesselinova A; Garbom S; Wolf-Watz H
Zoonoses Public Health; 2009 May; 56(4):157-68. PubMed ID: 18793276
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils are resistant to Yersinia YopJ/P-induced apoptosis and are protected from ROS-mediated cell death by the type III secretion system.
Spinner JL; Seo KS; O'Loughlin JL; Cundiff JA; Minnich SA; Bohach GA; Kobayashi SD
PLoS One; 2010 Feb; 5(2):e9279. PubMed ID: 20174624
[TBL] [Abstract][Full Text] [Related]
11. The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection.
Durand EA; Maldonado-Arocho FJ; Castillo C; Walsh RL; Mecsas J
Cell Microbiol; 2010 Aug; 12(8):1064-82. PubMed ID: 20148898
[TBL] [Abstract][Full Text] [Related]
12. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A
Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967
[TBL] [Abstract][Full Text] [Related]
13. DNA adenine methylase overproduction in Yersinia pseudotuberculosis alters YopE expression and secretion and host immune responses to infection.
Julio SM; Heithoff DM; Sinsheimer RL; Low DA; Mahan MJ
Infect Immun; 2002 Feb; 70(2):1006-9. PubMed ID: 11796641
[TBL] [Abstract][Full Text] [Related]
14. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues.
Logsdon LK; Mecsas J
Infect Immun; 2003 Aug; 71(8):4595-607. PubMed ID: 12874339
[TBL] [Abstract][Full Text] [Related]
15. Experimental infections with wild and mutant Yersinia pseudotuberculosis strains in rabbits.
Najdenski H; Vesselinova A; Golkocheva E; Garbom S; Wolf-Watz H
J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):280-8. PubMed ID: 14628999
[TBL] [Abstract][Full Text] [Related]
16. The RACK1 signaling scaffold protein selectively interacts with Yersinia pseudotuberculosis virulence function.
Thorslund SE; Edgren T; Pettersson J; Nordfelth R; Sellin ME; Ivanova E; Francis MS; Isaksson EL; Wolf-Watz H; Fällman M
PLoS One; 2011 Feb; 6(2):e16784. PubMed ID: 21347310
[TBL] [Abstract][Full Text] [Related]
17. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction.
Rüssmann H; Gerdemann U; Igwe EI; Panthel K; Heesemann J; Garbom S; Wolf-Watz H; Geginat G
Infect Immun; 2003 Jun; 71(6):3463-72. PubMed ID: 12761131
[TBL] [Abstract][Full Text] [Related]
18. The small RNA chaperone Hfq is required for the virulence of Yersinia pseudotuberculosis.
Schiano CA; Bellows LE; Lathem WW
Infect Immun; 2010 May; 78(5):2034-44. PubMed ID: 20231416
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis.
Dessein R; Gironella M; Vignal C; Peyrin-Biroulet L; Sokol H; Secher T; Lacas-Gervais S; Gratadoux JJ; Lafont F; Dagorn JC; Ryffel B; Akira S; Langella P; Nùñez G; Sirard JC; Iovanna J; Simonet M; Chamaillard M
Gut; 2009 Jun; 58(6):771-6. PubMed ID: 19174417
[TBL] [Abstract][Full Text] [Related]
20. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
